...
首页> 外文期刊>Molecular Metabolism >Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload
【24h】

Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload

机译:铁在没有铁过载的新型DB / DB小鼠模型中没有炎症的炎症中加重肝胰岛素抵抗力

获取原文
           

摘要

Objective The molecular pathogenesis of late complications associated with type 2 diabetes mellitus (T2DM) is not yet fully understood. While high glucose levels indicated by increased HbA1c only poorly explain disease progression and late complications, a pro-inflammatory status, oxidative stress, and reactive metabolites generated by metabolic processes were postulated to be involved. Individuals with metabolic syndrome (MetS) frequently progress to T2DM, whereby 70% of patients with T2DM show non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of MetS, and insulin resistance (IR). Epidemiological studies have shown that T2DM and steatosis are associated with alterations in iron metabolism and hepatic iron accumulation. Excess free iron triggers oxidative stress and a switch towards a macrophage pro-inflammatory status. However, so far it remains unclear whether hepatic iron accumulation plays a causative role in the generation of IR and T2DM or whether it is merely a manifestation of altered hepatic metabolism. To address this open question, we generated and characterized a mouse model of T2DM with IR, steatosis, and iron overload. Methods Lepr db/db mice hallmarked by T2DM, IR and steatosis were crossed with Fpn wt/C326S mice with systemic iron overload to generate Lepr db/db /Fpn wt/C326S mice. The resulting progeny was characterized for major diabetic and iron-related parameters. Results We demonstrated that features associated with T2DM in Lepr db/db mice, such as obesity, steatosis, or IR, reduce the degree of tissue iron overload in Fpn wt/C326S mice, suggesting an ‘iron resistance’ phenotype. Conversely, we observed increased serum iron levels that strongly exceeded those in the iron-overloaded Fpn wt/C326S mice. Increased hepatic iron levels induced oxidative stress and lipid peroxidation and aggravated IR, as indicated by diminished IRS1 phosphorylation and AKT activation. Additionally, in the liver, we observed gene response patterns indicative of de novo lipogenesis and increased gluconeogenesis as well as elevated free glucose levels. Finally, we showed that iron overload in Lepr db/db /Fpn wt/C326S mice enhances microvascular complications observed in retinopathy, suggesting that iron accumulation can enhance diabetic late complications associated with the liver and the eye. Conclusion Taken together, our data show that iron causes the worsening of symptoms associated with the MetS and T2DM. These findings imply that iron depletion strategies together with anti-diabetic drugs may ameliorate IR and diabetic late complications.
机译:目的尚不完全理解与2型糖尿病(T2DM)相关的晚期并发症的分子发病机制。虽然HBA1C增加的高葡萄糖水平仅涉及疾病进展和晚期并发症,但假设促使由代谢过程产生的促炎症状态,氧化应激和反应性代谢物。具有代谢综合征(METS)的个体经常进展到T2DM,其中70%的T2DM患者显示非酒精性脂肪肝疾病(NAFLD),MET的肝脏表现和胰岛素抵抗(IR)。流行病学研究表明,T2DM和脂肪变性与铁代谢和肝脏铁积累的改变有关。过量的游离铁触发氧化应激和切换朝向巨噬细胞促炎状态。然而,到目前为止,它仍然尚不清楚肝脏铁积累是否在IR和T2DM的产生中起到致病作用,或者是否仅仅是改变肝脏代谢的表现。为了解决这个打开的问题,我们生成并表征了带有IR,Steposis和铁过载的T2DM的鼠标模型。方法使用T2DM,IR和脂肪变性的LEPR DB / DB小鼠与具有全身铁过载的FPN WT / C326S小鼠交叉,以产生LEPR DB / DB / FPN WT / C326S小鼠。得到的后代特征在于主要糖尿病和相关参数。结果表明,在菌菌DB / DB小鼠中与T2DM相关的特征,例如肥胖,脂肪变性或IR,降低了FPN WT / C326S小鼠中的组织铁过载程度,表明了“铁抵抗力​​”表型。相反,我们观察到增加血清铁水平,强烈超过铁超载FPN WT / C326S小鼠。增加肝脏铁水水平诱导氧化应激和脂质过氧化和加重IR,如减少的IRS1磷酸化和AKT活化所示。另外,在肝脏中,我们观察到指示De Novo脂肪生成和增加的葡糖生成的基因反应模式以及升高的游离葡萄糖水平。最后,我们表明LEPR DB / DB / FPN WT / C326S小鼠的铁过载提高了视网膜病变中观察到的微血管并发症,表明铁积累可以增强与肝脏和眼睛相关的糖尿病后期并发症。结论在一起,我们的数据显示铁导致与Mets和T2DM相关的症状恶化。这些发现暗示铁耗尽策略与抗糖尿病药物一起可以改善IR和糖尿病后期并发症。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号